Skip to main content

Loxapine Tablets

Last Updated: June 15, 2022
Status: Current

Products Affected - Description
    • Loxapine oral tablet, Mylan Institutional, 10 mg, bottle, tablet 100 count, NDC 00378-7010-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 25 mg, bottle, tablet 100 count, NDC 00378-7025-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 5 mg, bottle, tablet 100 count, NDC 00378-7005-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 50 mg, bottle, tablet 100 count, NDC 00378-7050-01 - discontinued
    • Loxapine oral tablet, Teva, 10 mg, bottle, tablet 100 count, NDC 00591-0370-01
Reason for the Shortage
    • Teva has all but one presentation available.
    • Marlex has loxapine tablets available.
    • Lannett has loxapine tablets available.
    • Mylan Institutional discontinued loxapine tablets in June 2021.
Available Products
    • Loxapine oral tablet, Lannett, 10 mg, bottle, tablet 100 count, NDC 00527-1395-01
    • Loxapine oral tablet, Lannett, 25 mg, bottle, tablet 100 count, NDC 00527-1396-01
    • Loxapine oral tablet, Lannett, 5 mg, bottle, tablet 100 count, NDC 00527-1394-01
    • Loxapine oral tablet, Lannett, 50 mg, bottle, tablet 100 count, NDC 00527-1397-01
    • Loxapine oral tablet, Marlex, 10 mg, bottle, tablet 100 count, NDC 10135-0586-01
    • Loxapine oral tablet, Marlex, 25 mg, bottle, tablet 100 count, NDC 10135-0587-01
    • Loxapine oral tablet, Marlex, 5 mg, bottle, tablet 100 count, NDC 10135-0585-01
    • Loxapine oral tablet, Marlex, 50 mg, bottle, tablet 100 count, NDC 10135-0588-01
    • Loxapine oral tablet, Teva, 25 mg, bottle, tablet 100 count, NDC 00591-0371-01
    • Loxapine oral tablet, Teva, 5 mg, bottle, tablet 100 count, NDC 00591-0369-01
    • Loxapine oral tablet, Teva, 50 mg, bottle, tablet 100 count, NDC 00591-0372-01

Estimated Resupply Dates

    • Most presentations are available.

Updated

Updated June 15, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 12, 2019 by Rachael Freeman, PharmD, BCPS. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.